Lung issues are listed as less common side effects on letrazole and the hospital where Inwas admitted confirmed this.
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Letrozole and Respiratory Side Effects: What You're Experiencing
Thank you for that important clarification. You're absolutely right — pulmonary/respiratory issues are documented as less common but recognized side effects of letrozole, and the fact that your hospital team confirmed this connection to your case is significant clinical information.
What This Means Educationally:
Letrozole-associated pulmonary toxicity is a real, though uncommon, adverse effect that oncologists monitor for. Your hospital's confirmation suggests your breathing problems may be drug-related rather than coincidental, which is important information for your treatment decisions.
Letrozole vs. Anastrozole for Respiratory Concerns:
Since letrozole has a documented association with lung/breathing issues in your case:
Anastrozole may be a reasonable alternative to discuss because:
- It's also an aromatase inhibitor with similar efficacy for ER+ breast cancer
- Respiratory toxicity is not prominently documented as a side effect of anastrozole in the same way
- Both drugs work through similar mechanisms, so efficacy should be comparable
However, individual drug tolerability varies — some patients tolerate one AI better than another.
Questions to Ask Your Oncology Team:
- "Given my confirmed letrozole-related breathing problems, would switching to anastrozole be appropriate?"
- "How long should I wait after stopping letrozole before my lung function improves?"
- "Are there tests (like pulmonary function tests) to monitor my recovery?"
- "If anastrozole doesn't work well either, what are alternative endocrine therapy options?"
- "Should I have any cardiac or pulmonary follow-up given this adverse effect?"
Important Context:
Your hospital team's clinical assessment of the letrozole connection is the most reliable information here — they have your complete medical picture. Your oncologist is best positioned to weigh the benefits of continuing hormone therapy against the respiratory risk you've experienced.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with side effects for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2